Cicatricure Scar Spf 30
NDC Package 50066-034-01
Package Information
Cicatricure Scar Spf 30 is a . Marketed by Genomma Lab, this product is identified by NDC 50066-034 and is authorized under FDA application part352.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50066 - Genomma Lab
- 50066-034 - Cicatricure Scar Spf 30
- 50066-034-01 - 21 mL in 1 TUBE
- 50066-034 - Cicatricure Scar Spf 30
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50066-034-01 identifies a specific commercial package of 21 ml in 1 tube of Cicatricure Scar Spf 30, labeled by Genomma Lab. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genomma Lab on March 01, 2017. The current certification is valid through September 21, 2022.
How is this Genomma Lab product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50066003401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.